美股市场个股详情

MASI 麦斯莫医疗

添加自选

136.250
+2.240+1.67%

收盘价 05/02 16:00 (美东)

71.91亿总市值90.23市盈率TTM

麦斯莫医疗股票讨论区

登录发表评论

Movers and Shakers

04/15 20:48

专栏Today's Morning Movers and Top Ratings: GS, TSLA, CSCO, CRM and More

Morning Movers
Gapping up
$高盛(GS.US)$ Shares of Goldman Sachs surged 3.3% in premarket trading following the company's earnings report, which exceeded Wall Street's first-quarter expectations. The firm reported earnings of $11.58 per share on revenue of $14.21 billion, surpassing analysts' predictions of $8.56 per share and revenue of $12.92 billion, thanks to the strong performance of its trading and investment banki...

Movers and Shakers

03/25 20:13

专栏Today's Morning Movers and Top Ratings: AAPL, INTC, TSLA, DIS and More

Morning Movers
Gapping up
$迪士尼(DIS.US)$ 's stock enjoyed a 1.2% increase after a company spokesperson responded to activist investor Nelson Peltz's criticisms regarding the company's movie casting choices, using it as a reason to argue against his appointment to Disney's board.
$麦斯莫医疗(MASI.US)$ 's stock surged by 13% on news from the Wall Street Journal that Politan Capital Management is looking to propose two additional m...

Moomoo AI

03/25 07:06

Politan supports a review of Masimo's consumer business but expresses concerns over the company's corporate governance and doubts about the follow-through on the separation. Politan also feels that its directors have been marginalized by Kiani since joining the board.

Activist Politan Plans Second Proxy Battle at Masimo -- WSJ

iamiam

03/23 04:43

massive shout out to my friend @Buffalo who called this out! 👏
I was just lucky enough to buy
$麦斯莫医疗(MASI.US)$

Moomoo AI

03/01 00:05

Analysts predict a substantial slowdown in Masimo's revenue growth, with expectations of 2.6% annual growth until 2024, compared to a past rate of 21%. The wider industry is expected to outpace Masimo.

Masimo Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Moomoo AI

02/19 22:13

Despite EPS decline, market optimism persists for long-term earnings stability. Current sell-off could be a worthy opportunity if fundamentals indicate sustainable growth. Yet, two warning signs exist in Masimo's investment analysis, one being concerning.

Investors in Masimo (NASDAQ:MASI) Have Unfortunately Lost 46% Over the Last Three Years

Moomoo AI

01/18 06:22

The import ban could significantly impact Apple's competitiveness in the US smartwatch market and its overall financial performance. The ongoing legal dispute underscores the complexities of patent litigation in the tech industry and could potentially strengthen Masimo's position in the health tech market.

Masimo's Patent Win Stirs Apple Watch Market Disruption

Moomoo AI

01/18 04:51

The patent dispute with Masimo highlights the challenges Apple may face as it expands further into the health market, where established players and device makers may engage in prolonged patent disputes with the company.

Apple Loses Attempt to Delay U.S. Watch Ban

Moomoo AI

01/18 04:29

The import ban may hit Apple's smartwatch sales in the U.S., and the ongoing legal fight with Masimo could further stress the company's resources and reputation. The appeal process, expected to last over a year, could extend the uncertainty around Apple's smartwatch business.